108 related articles for article (PubMed ID: 6897285)
1. Potent anorexic-like effects of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in the rat: a comparison with other dopamine-receptor agonists.
Arnerić SP; Roetker A; Long JP
Neuropharmacology; 1982 Sep; 21(9):885-90. PubMed ID: 6897285
[TBL] [Abstract][Full Text] [Related]
2. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
[TBL] [Abstract][Full Text] [Related]
3. Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
Arnerić SP; Chow SA; Long JP; Fischer LJ
J Pharmacol Exp Ther; 1984 Mar; 228(3):551-9. PubMed ID: 6142939
[TBL] [Abstract][Full Text] [Related]
4. Effects of semirigid methoxamine analogs on vascular smooth muscle: studies of methoxy-2-aminotetralin and 2-aminoindane derivatives.
Arnerić SP; Roetker A; Long JP; Mott J; Barfknecht CF
Arch Int Pharmacodyn Ther; 1982 Jun; 257(2):263-73. PubMed ID: 7114973
[TBL] [Abstract][Full Text] [Related]
5. Evidence that a novel dopamine receptor agonist, RDS-127 [2-di-n-propylamino-4,7-dimethoxyindane] has some centrally mediated cardiovascular actions.
Arnerić SP; Long JP
J Pharm Pharmacol; 1984 May; 36(5):318-21. PubMed ID: 6145768
[TBL] [Abstract][Full Text] [Related]
6. Is domperidone a selective peripheral dopamine-receptor antagonist in vivo?
Arnerić SP; Collins ED; Bhatnagar RK; Long JP
Neuropharmacology; 1982 Dec; 21(12):1317-21. PubMed ID: 7155311
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the anorectic and motor activity effects of some aminoindanes, 2-aminotetralin and amphetamine in the rat.
Mrongovius RI; Bolt AG; Hellyer RO
Clin Exp Pharmacol Physiol; 1978; 5(6):635-40. PubMed ID: 719961
[TBL] [Abstract][Full Text] [Related]
8. Failure of pimozide and metergoline to antagonize the RDS-127-induced facilitation of ejaculatory behavior.
Clark JT; Smith ER
Physiol Behav; 1986; 37(1):47-52. PubMed ID: 3737722
[TBL] [Abstract][Full Text] [Related]
9. Further studies on alterations in male rat copulatory behavior induced by the dopamine-receptor agonist RDS-127.
Clark JT; Stefanick ML; Smith ER; Davidson JM
Pharmacol Biochem Behav; 1983 Nov; 19(5):781-6. PubMed ID: 6647512
[TBL] [Abstract][Full Text] [Related]
10. Behavioural microanalysis of the role of dopamine in amphetamine anorexia.
Towell A; Muscat R; Willner P
Pharmacol Biochem Behav; 1988 Jul; 30(3):641-8. PubMed ID: 3211973
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel dopamine-receptor agonist RDS-127 (2-N,N-di-n-propylamino-4,7-dimethoxyindane), on hormone levels and sexual behavior in the male rat.
Clark JT; Smith ER; Stefanick ML; Arnerić SP; Long JP; Davidson JM
Physiol Behav; 1982 Jul; 29(1):1-6. PubMed ID: 7122715
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of insulin release from rat pancreatic islets by drugs that are analogues of dopamine.
Arnerić SP; Chow SA; Long JP; Fischer LJ
Diabetes; 1984 Sep; 33(9):888-93. PubMed ID: 6147289
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of alpha-adrenoceptor agonistic activity of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in rabbit and rat aortae.
Rezaki YE; Ilhan M
Arch Int Pharmacodyn Ther; 1991; 310():76-86. PubMed ID: 1685313
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor agonists, N,N-dipropyl-2-aminotetralin (TL-68) and 2-di-n-propylamino-4,7-dimethoxyindane (RDS-127) antagonize oxotremorine-induced tremors by antimuscarinic action in mice.
Sahin I; Tuncer M; Ilhan M
Arch Int Physiol Biochim; 1990 Mar; 98(1):7-9. PubMed ID: 1692697
[TBL] [Abstract][Full Text] [Related]
15. The antimuscarinic activity of a dopamine receptor agonist (RDS-127) differentiates M2-muscarinic receptors of heart, ileum and trachea in guinea-pig.
Sahin I; Ilhan M
Arch Int Pharmacodyn Ther; 1988; 296():163-72. PubMed ID: 2907277
[TBL] [Abstract][Full Text] [Related]
16. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
Cheal M; Kurkulos ME; Silva L
Pharmacol Biochem Behav; 1982 Dec; 17(6):1305-8. PubMed ID: 6891794
[TBL] [Abstract][Full Text] [Related]
17. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
Svensson K; Johansson AM; Magnusson T; Carlsson A
Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
[TBL] [Abstract][Full Text] [Related]
18. The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity.
Dewey KJ; Fibiger HC
Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):261-70. PubMed ID: 6683359
[TBL] [Abstract][Full Text] [Related]
19. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
Arnt J; Overø KF; Hyttel J; Olsen R
Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
[TBL] [Abstract][Full Text] [Related]
20. Apomorphine anorexia: the role of dopamine receptors in the ventral forebrain.
Towell A; Willner P; Muscat R
Psychopharmacology (Berl); 1988; 96(1):135-41. PubMed ID: 2906442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
